Urine PD-L1 as a non-invasive biomarker for immune checkpoint inhibitor (ICI) therapy in bladder cancer
Qianyun Ge(The Ohio State University), Xuefeng Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Anil V. Parwani(The Ohio State University Wexner Medical Center), Shang-Jui Wang(The Ohio State University Wexner Medical Center), Peng Wang(The Ohio State University Wexner Medical Center), Lingbin Meng(The Ohio State University Wexner Medical Center), Jenny Li(The Ohio State University), Cheryl Lee(Agency for Science, Technology and Research)
Cited by 1
Related Papers
ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
|American Journal Of Pathology|2011|738
What Is Trophoblast? A Combination of Criteria Define Human First-Trimester Trophoblast
|Stem Cell Reports|2016|308
Standardization of Radical Cystectomy and Pelvic Lymph Node Dissection for Bladder Cancer: A Collaborative Group Report
|The Journal of Urology|2004|293
Long non‐coding RNA gadd7 interacts with TDP‐43 and regulates Cdk6 mRNA decay
|The EMBO Journal|2012|186
A high-resolution map of human RNA translation
|Molecular Cell|2022|154